Jisi Yingda
About:
Jisi Yingda is a small-molecule anti-cancer drug developer, in the field of small-molecule tumor immune drugs and tumor drug development.
Website: http://www.jsinnopharm.com/
Top Investors: Oriental Fortune Capital, Suzhou International Development Venture Capital, Baidu Ventures, Zhidao Capital, Jiuyou Capital
Description:
Jisi Yingda is a small-molecule anti-cancer drug developer, in the field of small-molecule tumor immune drugs and tumor drug development.
Total Funding Amount:
100M CNY
Headquarters Location:
Shanghai, Shanghai, China
Founded Date:
2010-11-01
Contact Email:
contact(AT)jsinnopharm.com
Founders:
Jintao Zhang
Number of Employees:
11-50
Last Funding Date:
2021-11-15
IPO Status:
Private
Industries:
© 2025 bioDAO.ai